Search Results for keywords:"commercialization"

Found 4 results

Search Results: keywords:"commercialization"

💰 Only
Oldest Newest
  • 2021-04069 — Government-Owned Inventions; Availability for Licensing
    Type:Notice
    Citation:86 FR 12007
    Reading Time:about 2 minutes

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), announced that certain government-owned inventions are available for licensing. One such invention involves the use of statins, like atorvastatin, to prevent hearing loss caused by chemotherapy drugs like cisplatin. Hearing loss is a common side effect for many cancer patients undergoing treatment, and statins are being explored to mitigate this issue. The announcement highlights both the potential applications for these statins in preventing hearing loss and the readiness of the technology for commercial development.

    Simple Explanation

    The government has some cool ideas, like using certain medicines to help people not lose their hearing during cancer treatment, and they're looking for people or companies to help make these ideas real and useful for everyone.

  • 2021-03872 — Government-Owned Inventions; Availability for Licensing
    Type:Notice
    Citation:86 FR 11546
    Reading Time:about 2 minutes

    The U.S. Government owns a new invention for an improved live-attenuated vaccine targeting Respiratory Syncytial Virus (RSV) and is now offering it for licensing. The technology involves a vaccine developed by altering certain RSV genes to create a version of the virus that stays stable and is weakened enough to be safe for use as a vaccine. This vaccine could potentially help protect infants, young children, and older adults from serious respiratory diseases caused by RSV and is designed to be administered intranasally. The National Institute of Allergy and Infectious Diseases is looking for commercial partners to develop and evaluate this vaccine further.

    Simple Explanation

    The government has a new tool to help stop a germ that makes people's noses and lungs sick, especially in babies and grandparents, and they're looking for companies to help make it into a medicine you can spray up your nose.

  • 2021-03044 — Government-Owned Inventions; Availability for Licensing
    Type:Notice
    Citation:86 FR 9521
    Reading Time:about 2 minutes

    The National Institutes of Health (NIH) is offering a new invention for licensing, aiming to quickly commercialize results from government-funded research. This invention involves a vaccine technology, developed by NIH, that uses adenovirus type 4 to stimulate an immune response against SARS-CoV-2. The vaccine offers benefits like durable immunity and ease of distribution and is available for companies to license. Interested parties can obtain further information and discuss collaboration opportunities by contacting Chris Kornak from the NIH.

    Simple Explanation

    The United States government has come up with a new way to make vaccines, and they want companies to use it to help keep people healthy. If a company wants to know more or work with the government on this, they have to follow some special steps and rules.

  • 2021-01490 — Government-Owned Inventions; Availability for Licensing
    Type:Notice
    Citation:86 FR 6891
    Reading Time:about 3 minutes

    The National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), is offering a new invention for licensing. This invention involves a pre-fusion stabilized F glycoprotein vaccine immunogen designed to combat human metapneumovirus (hMPV), a virus responsible for respiratory illnesses in children and the elderly. The NIH aims to transfer this federally-funded research technology to commercial developers, enhancing vaccine options. This vaccine candidate shows promise due to its ability to elicit strong neutralizing antibodies and has no current market competition for this specific health issue.

    Simple Explanation

    The government has invented a new type of vaccine to help protect people, especially kids and older adults, from getting sick with a virus called hMPV. They are looking for companies to help make and sell the vaccine, but they haven't shared all the extra details on how they choose who can help or any challenges they might face.